Kevin R. Flaherty

机构：University of Michigan, Michigan Medicine · ORCID：0000-0001-7686-0291

发表论文 357 篇 · 总被引 27978 次 · h-index 78

代表论文

• Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 88)
• Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 76)
• Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis (2023 · European Respiratory Journal · 被引 57)
• Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 52)
• Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis (2024 · Annals of the American Thoracic Society · 被引 19)
• Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 14)